Bioactive Materials,
Год журнала:
2021,
Номер
8, С. 20 - 34
Опубликована: Июнь 26, 2021
Photodynamic
therapy
(PDT)
has
been
applied
in
clinical
treatment
of
tumors
for
a
long
time.
However,
insufficient
supply
pivotal
factors
including
photosensitizer
(PS),
light,
and
oxygen
tumor
tissue
dramatically
reduces
the
therapeutic
efficacy
PDT.
Nanoparticles
have
received
an
influx
attention
as
drug
carriers,
recent
studies
demonstrated
their
promising
potential
to
overcome
obstacles
PDT
tissue.
Physicochemical
optimization
passive
targeting,
ligand
modification
active
stimuli-responsive
release
achieved
efficient
delivery
PS
Various
trials
using
upconversion
NPs,
two-photon
lasers,
X-rays,
bioluminescence
provided
clues
methods
light
deep
Attempts
made
unfavorable
microenvironments
via
artificial
generation,
Fenton
reaction,
combination
with
other
chemical
drugs.
In
this
review,
we
introduce
these
creative
approaches
addressing
hurdles
facing
tumors.
particular,
that
validated
animal
experiments
are
preferred
review
over
proof-of-concept
were
only
performed
cells.
Chemical Reviews,
Год журнала:
2021,
Номер
121(21), С. 13454 - 13619
Опубликована: Сен. 28, 2021
This
review
presents
a
robust
strategy
to
design
photosensitizers
(PSs)
for
various
species.
Photodynamic
therapy
(PDT)
is
photochemical-based
treatment
approach
that
involves
the
use
of
light
combined
with
light-activated
chemical,
referred
as
PS.
Attractively,
PDT
one
alternatives
conventional
cancer
due
its
noninvasive
nature,
high
cure
rates,
and
low
side
effects.
PSs
play
an
important
factor
in
photoinduced
reactive
oxygen
species
(ROS)
generation.
Although
concept
photosensitizer-based
photodynamic
has
been
widely
adopted
clinical
trials
bioimaging,
until
now,
our
surprise,
there
no
relevant
article
on
rational
designs
organic
PDT.
Furthermore,
most
published
articles
focused
nanomaterials
nanotechnology
based
traditional
PSs.
Therefore,
this
aimed
at
reporting
recent
strategies
develop
innovative
enhanced
therapy,
each
example
described
detail
instead
providing
only
general
overview,
typically
done
previous
reviews
PDT,
provide
intuitive,
vivid,
specific
insights
readers.
Advanced Materials,
Год журнала:
2021,
Номер
33(48)
Опубликована: Сен. 27, 2021
Photodynamic
therapy
(PDT)
has
aroused
great
research
interest
in
recent
years
owing
to
its
high
spatiotemporal
selectivity,
minimal
invasiveness,
and
low
systemic
toxicity.
However,
due
the
hypoxic
nature
characteristic
of
many
solid
tumors,
PDT
is
frequently
limited
therapeutic
effect.
Moreover,
consumption
O2
during
may
further
aggravate
tumor
condition,
which
promotes
proliferation,
metastasis,
invasion
resulting
poor
prognosis
treatment.
Therefore,
numerous
efforts
have
been
made
increase
content
with
goal
enhancing
efficacy.
Herein,
these
strategies
developed
past
decade
are
comprehensively
reviewed
alleviate
hypoxia,
including
1)
delivering
exogenous
directly,
2)
generating
situ,
3)
reducing
cellular
by
inhibiting
respiration,
4)
regulating
TME,
(e.g.,
normalizing
vasculature
or
disrupting
extracellular
matrix),
5)
hypoxia-inducible
factor
1
(HIF-1)
signaling
pathway
relieve
hypoxia.
Additionally,
-independent
Type-I
also
discussed
as
an
alternative
strategy.
By
reviewing
progress,
it
hoped
that
this
review
will
provide
innovative
perspectives
new
nanomaterials
designed
combat
hypoxia
avoid
associated
limitation
PDT.
Photodynamic
therapy
(PDT)
has
shown
great
potential
for
tumor
treatment
with
merits
of
non-invasiveness,
high
selectivity,
and
minimal
side
effects.
However,
conventional
type
II
PDT
relying
on
1
O2
presents
poor
therapeutic
efficacy
hypoxic
tumors
due
to
the
oxygen-dependent
manner.
Alternatively,
emerging
researches
have
demonstrated
that
I
exhibits
superiority
over
in
owing
its
diminished
oxygen-dependence.
In
this
review,
state-of-the-art
studies
concerning
recent
progress
photosensitizers
are
scrutinized,
emphasizing
strategies
construct
highly
effective
photosensitizers.
As
foundation,
basic
principles
presented,
up-to-date
summarized
classified
based
their
attributes.
Then,
a
literature
review
representative
(including
nanomaterials
small
molecules)
is
presented
impetus
delineate
novel
designs,
action
mechanisms,
as
well
anticancer
applications.
Finally,
remaining
challenges
development
directions
outlined,
highlighting
key
scientific
issues
toward
clinical
translations.
Angewandte Chemie International Edition,
Год журнала:
2021,
Номер
60(36), С. 19912 - 19920
Опубликована: Июль 6, 2021
Abstract
Developing
Type‐I
photosensitizers
is
considered
as
an
efficient
approach
to
overcome
the
deficiency
of
traditional
photodynamic
therapy
(PDT)
for
hypoxic
tumors.
However,
it
remains
a
challenge
design
generating
reactive
oxygen
species
by
process.
Herein,
we
report
series
α,β‐linked
BODIPY
dimers
and
trimer
that
exclusively
generate
superoxide
radical
(O
2
−.
)
process
upon
light
irradiation.
The
triplet
formation
originates
from
effective
excited‐state
relaxation
initially
populated
singlet
(S
1
(T
states
via
intermediate
state.
low
reduction
potential
ultralong
lifetime
T
state
facilitate
generation
O
inter‐molecular
charge
transfer
molecular
oxygen.
energy
gap
‐S
0
smaller
than
between
3
thereby
precluding
Type‐II
exhibits
superior
PDT
performance
under
environment.
Journal of the American Chemical Society,
Год журнала:
2023,
Номер
145(7), С. 4081 - 4087
Опубликована: Фев. 13, 2023
The
highly
oxygen-dependent
nature
of
photodynamic
therapy
(PDT)
limits
its
therapeutic
efficacy
against
hypoxic
solid
tumors
in
clinics,
which
is
an
urgent
problem
to
be
solved.
Herein,
we
develop
oxygen-independent
supramolecular
agent
that
produces
hydroxyl
radical
(•OH)
by
oxidizing
water
the
presence
intracellularly
abundant
pyruvic
acid
under
oxygen-free
conditions.
A
fluorene-substituted
BODIPY
was
designed
as
electron
donor
and
coassembled
with
perylene
diimide
acceptor
form
quadruple
hydrogen-bonded
agent.
Detailed
mechanism
studies
reveal
intermolecular
transfer
charge
separation
upon
light
irradiation
result
efficient
generation
ion
pairs.
Under
conditions,
cationic
radicals
directly
oxidize
generate
cytotoxic
•OH,
anionic
electrons
acid,
realizing
catalytic
cycle.
Thus,
this
exhibited
superb
photocytotoxicity
even
severe
environments
excellent
vivo
antitumor
on
HeLa-bearing
mouse
models.
This
work
provides
a
strategy
for
constructing
agents,
opens
up
avenue
effective
PDT
tumors.
Journal of the American Chemical Society,
Год журнала:
2022,
Номер
144(25), С. 11326 - 11337
Опубликована: Июнь 16, 2022
Pyroptosis,
a
newly
characterized
form
of
immunogenic
cell
death,
is
attracting
increasing
attention
as
promising
approach
to
cancer
immunotherapy.
However,
biocompatible
strategies
activate
pyroptosis
remain
rare.
Here,
we
show
that
photocatalytic
superoxide
radical
(O2-•)
generator,
NI-TA,
triggers
in
cells.
NI-TA
was
designed
take
advantage
an
intramolecular
triplet-ground
state
splitting
energy
modulation
approach.
Detailed
studies
revealed
the
triggered
by
under
conditions
photoexcitation
proceeds
through
caspase-3/gasdermin
E
(GSDME)
pathway
rather
than
via
canonical
processes
involving
caspase-1/gasdermin-D
(GSDMD).
found
function
partial-O2-recycling
mode
action
and
trigger
provide
for
effective
ablation
even
hypoxia
(≤2%
O2).
In
case
T47D
3D
multicellular
spheroids,
good
antitumor
efficiency
stemness
inhibition
are
achieved.
This
work
highlights
how
chemistry
may
be
leveraged
develop
pyroptosis-inducing
agents.
Journal of the American Chemical Society,
Год журнала:
2021,
Номер
143(34), С. 13980 - 13989
Опубликована: Авг. 24, 2021
Most
photodynamic
therapy
(PDT)
paradigms
work
through
the
highly
O2-dependent
type
II
photoreaction
to
generate
singlet
oxygen
(1O2).
The
hypoxic
microenvironment
of
solid
tumors
severely
hampers
therapeutic
outcomes.
Here,
we
present
a
novel
design
that
could
transfer
photophysical
and
photochemical
properties
traditional
phthalocyanine-based
photosensitizers
from
efficient
I
vibrational
relaxation-induced
photothermal
conversion.
These
features
enable
obtained
nanostructured
phthalocyanine
assemblies
(e.g.,
NanoPcAF)
display
excellent
phototherapies
under
both
normoxic
conditions.
Moreover,
NanoPcAF
has
high
level
accumulation
in
tumor
tissues
after
intravenous
injection,
94%
growth
is
inhibited
preclinical
model
at
dose
0.8
nmol
g–1
light
300
J
cm–2.